1. 1. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358: 958-965, 2001.
2. 2. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982, 2002.
3. 3. Sakai A, Kaneko S, Matsushita E, Kobayashi K. Floating density of hepatitis C virus particles and response to interferon treatment. J Med Virol 55: 12-17, 1998.
4. 4. Sakai A, Kaneko S, Kobayashi K. Immunoadsorption therapy for HCV infected chimpanzee. Nippon Rinsho 59: 1374-1378, 2001 (in Japanese).
5. 5. Yamashita T, Arai K, Sakai A, et al. Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: a preliminary study. Hepatol Res 36: 167-175, 2006.